Company profile

Folia Health

Chronic Disease Management & Digital Therapeutics

Company profile

About Folia Health

Folia Health is a digital health platform founded by family caregivers that helps individuals with chronic and rare conditions transform their daily health experiences into structured data insights. The company's mobile app enables users to quickly capture what they call 'home-reported outcomes' (HROs) - observations about symptoms, treatments, flare-ups, and overall wellbeing - in 90 seconds or less. With over 40,000 users who have shared 4.5 million home-reported outcomes, Folia serves as a comprehensive health tracking solution that helps patients spot patterns, understand correlations, and make data-driven decisions about their care. The platform supports all rare and chronic conditions, with specialized in-app customizations for conditions including Paroxysmal Nocturnal Hemoglobinuria (PNH), Eczema, Lupus, Sickle Cell Disease, IgA Nephropathy (IgAN), and High Triglycerides. Users maintain full control over their data and can optionally participate in paid research studies or the Data Dividends program, earning compensation for contributing de-identified data to medical research. For life sciences companies, Folia offers an end-to-end research solution that addresses common real-world data challenges. The platform captures high-fidelity, patient-driven insights about disease heterogeneity, treatment patterns, and therapy impact that traditional clinical endpoints often miss. Services include protocol design, multi-channel recruitment, validated ePRO deployment, data linkage to EMR and claims data, and comprehensive analysis and reporting. The company's proprietary methodology enables precision outcomes measurement by capturing health experiences in near real-time outside clinical settings, providing a more complete understanding of patient phenotypes and response to therapy.

Company description Folia Health official website

Primary marketChronic Disease Management & Digital Therapeutics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Folia Health?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • All rare and chronic conditions
  • C3G
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Eczema
  • Fibromyalgia
  • High Triglycerides
  • IgA Nephropathy (IgAN)
  • Lupus
  • MPGN
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Prader-Willi Syndrome (PWS)
  • Sickle Cell Disease

Who it serves

  • Biotech companies
  • Caregivers
  • Consumers with chronic/rare conditions
  • Life Sciences companies
  • Pharmaceutical companies

Deployment & integration

Cloud Saas deployment with recorded integration context.

Recorded integration context: Claims data, EMR, Registry data, Wearables.

Geographic context

MarketsUnited States
Company sourceOfficial website

Company milestones

Platform expansion

Active research studies including BRAVE-PWS Caregiver Study, CIDP Compass Study, IgAN Bridge Study, PNH Study, and Connect C3G Study. Data Dividends program offering $4/month for users who share data for research.

Partnerships

Recorded partners

No partners are currently listed.

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Data Dividends Program

Earn gift cards for tracking health data and contributing to research

Service · Cloud SaaSCompany source

Folia Health App

Health tracking app transforming lived experiences into structured data insights for chronic conditions

Software · Cloud SaaSCompany source

Folia Research Platform

End-to-end outcomes research platform for heterogeneous conditions using home-reported outcomes

Platform · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

4.5 million home-reported outcomes

Captured from user community

40,000+ users

Active users tracking health on platform

90 seconds or less

Time to capture daily health observations

Neurology Biotech (Vice President, HEOR)

Demonstrating full therapy value beyond traditional clinical endpoints for approval and reimbursement

Bridged disconnect between endpoints needed for Approval vs. Reimbursement

Top 10 Pharma (Executive Director, WW HEOR RWD)

Gaining insights beyond traditional PROs without relying on long recall periods

Provides nuanced insights not available from traditional PROs with reduced recall bias

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

06 · Company updates

Updates from Folia Health

Recent articles published on Folia Health's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Chronic Disease Management & Digital Therapeutics

Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon